A somatic mutation of the KEAP1 gene in malignant melanoma is involved in aberrant NRF2 activation and an increase in intrinsic drug resistance

Shinpei Miura, Masahiko Shibazaki, Shuya Kasai, Shinji Yasuhira, Ayano Watanabe, Tsuyoshi Inoue, Yuich Kageshita, Kanako Tsunoda, Kazuhiro Takahashi, Toshihide Akasaka, Tomoyuki Masuda, Chihaya Maesawa

    研究成果: Letter

    19 引用 (Scopus)
    元の言語English
    ページ(範囲)553-556
    ページ数4
    ジャーナルJournal of Investigative Dermatology
    134
    発行部数2
    DOI
    出版物ステータスPublished - 2014 2

    ASJC Scopus subject areas

    • Biochemistry
    • Molecular Biology
    • Dermatology
    • Cell Biology

    これを引用

    Miura, S., Shibazaki, M., Kasai, S., Yasuhira, S., Watanabe, A., Inoue, T., Kageshita, Y., Tsunoda, K., Takahashi, K., Akasaka, T., Masuda, T., & Maesawa, C. (2014). A somatic mutation of the KEAP1 gene in malignant melanoma is involved in aberrant NRF2 activation and an increase in intrinsic drug resistance. Journal of Investigative Dermatology, 134(2), 553-556. https://doi.org/10.1038/jid.2013.343